What is the recommended dosing for midazolam (Benzodiazepine) infusion in treating status epilepticus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midazolam Infusion for Status Epilepticus

For refractory status epilepticus not controlled by standard therapies, midazolam should be administered as an IV loading dose of 0.15-0.20 mg/kg, followed by a continuous infusion starting at 1 mg/kg per minute and increasing by 1 mg/kg per minute increments every 15 minutes as needed, up to a maximum of 5 mg/kg per minute until seizures stop. 1

Dosing Protocol

Initial Loading Dose

  • IV loading dose: 0.15-0.20 mg/kg 1
  • This should be administered immediately upon determination that status epilepticus is refractory to standard first-line therapies 2

Continuous Infusion

  • Start at 1 mg/kg per minute 1
  • Increase by increments of 1 mg/kg per minute every 15 minutes 1
  • Maximum dose: 5 mg/kg per minute 1
  • Continue titration until seizures stop 1

Alternative Routes When IV Access is Challenging

  • IM administration: 0.2 mg/kg (maximum: 6 mg per dose) 1
  • May repeat IM dose every 10-15 minutes as needed 1
  • Note that IM administration has been shown to be more effective than intranasal administration in real-world settings 3

Monitoring and Safety Considerations

Respiratory Monitoring

  • Increased incidence of apnea when combined with other sedative agents 1
  • Be prepared to provide respiratory support regardless of administration route 1
  • Continuous oxygen saturation monitoring is essential 1

Reversal Agent Considerations

  • Flumazenil may be administered to reverse life-threatening respiratory depression 1
  • Important caveat: Flumazenil will also reverse the anticonvulsant effects and may precipitate recurrence of seizures 1

Clinical Efficacy

  • Midazolam has proven to be effective, well-tolerated, and fast-acting for refractory status epilepticus 2
  • Pharmacodynamic effects can be seen within 1-5 minutes of administration 2
  • Anticonvulsive effects typically appear within 5-15 minutes after administration 2
  • Clinical studies have documented cessation of seizure activity within minutes of the loading dose 4

Treatment Algorithm for Status Epilepticus

  1. First-line therapy: Standard benzodiazepines (lorazepam, diazepam) 1
  2. Second-line therapy: Phenytoin/fosphenytoin, valproate, or levetiracetam 1
  3. For refractory status epilepticus (seizures continuing after steps 1 and 2):
    • Initiate midazolam infusion as described above 1
    • The European Federation of Neurological Societies recommends anesthetic doses of midazolam, propofol, or barbiturates for status epilepticus refractory to benzodiazepines and phenytoin 1

Common Pitfalls and Caveats

  • Underdosing is a common pitfall - higher doses are associated with lower risk of rescue therapy 3
  • Hemodynamic instability may occur with prolonged infusions - monitor for hypotension 4
  • Withdrawal symptoms may occur with abrupt discontinuation - consider progressive reduction of doses when discontinuing 5
  • Concurrent treatment of underlying causes of status epilepticus (hypoglycemia, hyponatremia, hypoxia, drug toxicity, CNS infection) is essential 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.